Post-marketing safety evaluation of S-1 in patients with inoperable or recurrent breast cancer: especially in patients treated with S-1 + trastuzumab (Q35185472)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Post-marketing safety evaluation of S-1 in patients with inoperable or recurrent breast cancer: especially in patients treated with S-1 + trastuzumab |
scientific article |
Statements
1 reference
Post-marketing safety evaluation of S-1 in patients with inoperable or recurrent breast cancer: especially in patients treated with S-1 + trastuzumab (English)
1 reference
Yuki Saito
1 reference
Risa Oshitanai
1 reference
Mayako Terao
1 reference
Mizuho Terada
1 reference
Banri Tsuda
1 reference
Takuho Okamura
1 reference
Yasuhiro Suzuki
1 reference
Yutaka Tokuda
1 reference
2 August 2011
1 reference
1 reference
41
1 reference
9
1 reference
1051-1058
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference